Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2008;117:2986-2994
Published online before print June 2, 2008, doi: 10.1161/CIRCULATIONAHA.107.748814
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/23/2986    most recent
CIRCULATIONAHA.107.748814v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gonzalez, F. M.
Right arrow Articles by Arai, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gonzalez, F. M.
Right arrow Articles by Arai, A. E.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Attack
Hazardous Substances DB
*NITRIC OXIDE
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Animal models of human disease
Right arrow Ischemic biology - basic studies
Right arrow CT and MRI
Right arrow Acute myocardial infarction
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2008;117:2986-2994.)
© 2008 American Heart Association, Inc.


Molecular Cardiology

Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction

Felix M. Gonzalez, BS; Sruti Shiva, PhD; Pamela S. Vincent, RT; Lorna A. Ringwood, BS; Li-Yueh Hsu, DSc; Yuen Yi Hon, PharmD; Anthony H. Aletras, PhD; Richard O. Cannon, III, MD; Mark T. Gladwin, MD; Andrew E. Arai, MD

From the Translational Medicine Branch (F.M.G., P.S.V., L.H., A.H.A., R.O.C., A.E.A.) and Pulmonary-Vascular Medicine Branch (S.S., L.A.R., M.T.G.), National Heart, Lung, and Blood Institute; Critical Care Medicine Department (S.S., L.A.R., M.T.G.) and Pharmacy Department (Y.Y.H.), Clinical Center, National Institutes of Health; and Howard Hughes Medical Institute, National Institutes of Health Research Scholars Program (F.M.G.), Bethesda, Md.

Correspondence to Andrew Arai, MD, National Heart, Lung, and Blood Institute, National Institutes of Health, Bldg 10, Room B1D416, MSC 1061, 10 Center Dr, Bethesda, MD 20892-1061. E-mail araia{at}nih.gov

Received October 27, 2007; accepted March 12, 2008.

Background— Accumulating evidence suggests that the ubiquitous anion nitrite (NO2) is a physiological signaling molecule, with roles in intravascular endocrine nitric oxide transport, hypoxic vasodilation, signaling, and cytoprotection. Thus, nitrite could enhance the efficacy of reperfusion therapy for acute myocardial infarction. The specific aims of this study were (1) to assess the efficacy of nitrite in reducing necrosis and apoptosis in canine myocardial infarction and (2) to determine the relative role of nitrite versus chemical intermediates, such as S-nitrosothiols.

Methods and Results— We evaluated infarct size, microvascular perfusion, and left ventricular function by histopathology, microspheres, and magnetic resonance imaging in 27 canines subjected to 120 minutes of coronary artery occlusion. This was a blinded, prospective study comparing a saline control group (n=9) with intravenous nitrite during the last 60 minutes of ischemia (n=9) and during the last 5 minutes of ischemia (n=9). In saline-treated control animals, 70±10% of the area at risk was infarcted compared with 23±5% in animals treated with a 60-minute nitrite infusion. Remarkably, a nitrite infusion in the last 5 minutes of ischemia also limited the extent of infarction (36±8% of area at risk). Nitrite improved microvascular perfusion, reduced apoptosis, and improved contractile function. S-Nitrosothiol and iron-nitrosyl-protein adducts did not accumulate in the 5-minute nitrite infusion, suggesting that nitrite is the bioactive intravascular nitric oxide species accounting for cardioprotection.

Conclusions— Nitrite has significant potential as adjunctive therapy to enhance the efficacy of reperfusion therapy for acute myocardial infarction.


 

CLINICAL PERSPECTIVE




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
C. Jung, A. T. Gonon, P.-O. Sjoquist, J. O. Lundberg, and J. Pernow
Arginase inhibition mediates cardioprotection during ischaemia-reperfusion
Cardiovasc Res, September 18, 2009; (2009) cvp303v2.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. Dezfulian, S. Shiva, A. Alekseyenko, A. Pendyal, D.G. Beiser, J. P. Munasinghe, S. A. Anderson, C. F. Chesley, T.L. Vanden Hoek, and M. T. Gladwin
Nitrite Therapy After Cardiac Arrest Reduces Reactive Oxygen Species Generation, Improves Cardiac and Neurological Function, and Enhances Survival via Reversible Inhibition of Mitochondrial Complex I
Circulation, September 8, 2009; 120(10): 897 - 905.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. W. Calvert and D. J. Lefer
Myocardial protection by nitrite
Cardiovasc Res, July 15, 2009; 83(2): 195 - 203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
N. G Hord, Y. Tang, and N. S Bryan
Food sources of nitrates and nitrites: the physiologic context for potential health benefits
Am. J. Clinical Nutrition, July 1, 2009; 90(1): 1 - 10.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
D. Tsikas and R. Rossi
Letter by Tsikas and Rossi Regarding Article, "Nitrite Anion Provides Potent Cytoprotective and Antiapoptotic Effects as Adjunctive Therapy to Reperfusion for Acute Myocardial Infarction"
Circulation, May 19, 2009; 119(19): e531 - e531.
[Full Text] [PDF]


Home page
Circ. Res.Home page
D. H. Perlman, S. M. Bauer, H. Ashrafian, N. S. Bryan, M. F. Garcia-Saura, C. C. Lim, B. O. Fernandez, G. Infusini, M. E. McComb, C. E. Costello, et al.
Mechanistic Insights Into Nitrite-Induced Cardioprotection Using an Integrated Metabolomic/Proteomic Approach
Circ. Res., March 27, 2009; 104(6): 796 - 804.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
G. J. Kato and M. T. Gladwin
Evolution of Novel Small-Molecule Therapeutics Targeting Sickle Cell Vasculopathy
JAMA, December 10, 2008; 300(22): 2638 - 2646.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Feelisch, B. O. Fernandez, N. S. Bryan, M. F. Garcia-Saura, S. Bauer, D. R. Whitlock, P. C. Ford, D. R. Janero, J. Rodriguez, and H. Ashrafian
Tissue Processing of Nitrite in Hypoxia: AN INTRICATE INTERPLAY OF NITRIC OXIDE-GENERATING AND -SCAVENGING SYSTEMS
J. Biol. Chem., December 5, 2008; 283(49): 33927 - 33934.
[Abstract] [Full Text] [PDF]